Table 1

Relationship between clinical and pathological features and breast carcinomas expressing the immunophenotype CD44+CD24-/low and carcinomas that do not express this immunophenotype

Feature

CD44+CD24-/low positive

CD44+CD24-/low negative

p-value


Age (years)

0.789


< 50

38

66


> 50

51

98



Menopausal status

0.131


Pre

38

53


Post

51

111



Tumor size (cm)

0.837


< 2

24

49


2-5

39

66


> 5

26

49



Bloom & Richardson

0.319


I

28

66


II

48

73


III

13

25



Clinical Staging

0.219


I

12

21


IIa

21

40


IIb

19

34


IIIa

6

20


IIIb

22

44


IV

9

5



Recurrence

1.000


Yes

11

21


No

78

143



Lymph node status

0.895


Pos

47

89


Neg

42

75



Distant metastasis

0.479


Yes

30

48


No

59

116



Death

0.035*


Yes

37

46


No

52

118



*Statistically significant.

Oliveira-Costa et al. Diagnostic Pathology 2011 6:73   doi:10.1186/1746-1596-6-73

Open Data